Raytheon Awarded Contract to Retrofit GaN Technology for AN/TPY-2 Radars

The U.S. Missile Defense Agency has awarded Raytheon Company a contract modification to develop a transition to production process to incorporate Gallium Nitride, or GaN, components into existing and future AN/TPY-2 radars. This initial effort will support the transition from Gallium Arsenide to GaN technology, which would further modernize the ballistic missile defense radar and drive down system obsolescence.

A critical element in the ballistic missile defense system, Raytheon's AN/TPY-2 continually searches the sky for ballistic missiles. Credit: PRNewsFoto/Raytheon Company

As demonstrated in other Raytheon-developed military radar applications, Gallium Nitride has the capability to enhance range, increase detection and discrimination performance and lower production costs.

Currently fielded AN/TPY-2 radars use Gallium Arsenide (GaAs) based transmit/receive modules to emit high power radiation. Raytheon and MDA are pursuing a retrofit approach to leverage Gallium Nitride elements.

"GaN components have significant, proven advantages when compared to the previous generation GaAs technology," said Raytheon's Dave Gulla, vice president of the Integrated Defense Systems Mission Systems and Sensors business area. "Through this effort, Raytheon will develop a clear modernization upgrade path for the AN/TPY-2 radar, enabling the system to better defend people and critical assets against ballistic missile threats at home and abroad."

The AN/TPY-2 is a transportable X-band radar that protects civilians and infrastructure in the U.S., deployed military personnel, and allied nations and security partners from the growing ballistic missile threat. According to recent Congressional testimony by the director of the U.S. Missile Defense Agency, the threat is growing as potential adversaries acquire a greater number of ballistic missiles, increase their range, incorporate countermeasures and make them more complex, survivable, reliable and accurate.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.